Status | Study |
Not yet recruiting |
Study Name: The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas Condition: Tracheostomy Infection Date: 2017-04-18 Interventions: Drug: Inhaled Aztreonam Inhaled antibiotic with anti-pseudomonal properties |
Recruiting |
Study Name: Aerucin® in P. Aeruginosa Pneumonia Condition: Pseudomonas Aeruginosa Pneumonia Date: 2017-01-17 Interventions: Drug: aerubumab monoclonal ant |
Recruiting |
Study Name: Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects Condition: Pseudomonas Aeruginosa Date: 2016-02-11 Interventions: Drug: MEDI3902 Active |
Recruiting |
Study Name: Observational Study in Cystic Fibrosis Patients Using TOBI® Podhaler™ or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs Condition: Pseudomonas Aeruginosa in Cystic Fibrosis Date: 2015-05-04 Interventions: Drug: TOBI Podhaler Drug: TOBI |
Terminated |
Study Name: Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa Condition: Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis Date: 2014-09-22 Interventions: Drug: TIS or TIP 300mg nebulized Tobramycin (Tobramycin inhalation solution(TIS)) or TOBI Podhaler (Tobr |
Completed |
Study Name: Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy Subjects Condition: Pseudomonas Infection Date: 2014-06-26 Interventions: Drug: Fosfomycin tromethamine |
Completed |
Study Name: Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection Condition: Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa Date: 2014-03-06 Interventions: Drug: Tobramycin |
Recruiting |
Study Name: Impact of the Contamination Mode on the Clinical Evolution During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia (PYO GEN) Condition: Pseudomonas Aeruginosa Ventilation Acquired Pneumonia Date: 2012-10-08 |
Completed |
Study Name: Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43 Condition: Pseudomonas Aeruginosa Infection Date: 2012-03-14 Interventions: Biological: IC43 100 mcg |
Completed |
Study Name: The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis Condition: Pseudomonas Aeruginosa Cystic Fibrosis Date: 2012-01-09 |